Frank Pallone,
H.R. 3 Title II
(2021)
“ DETERMINATION OF INFLATION-ADJUSTED PAYMENT AMOUNT.—The inflation-adjusted payment amount determined under this subparagraph for a part B rebatable drug for a calendar quarter is— “ (i) the payment amount for the billing and payment code for such drug in the payment amount benchmark quarter (as defined in subparagraph (D) ) ; increased by “ (ii) the percentage by which the rebate period CPI–U (as defined in subparagraph (F) ) for the calendar quarter exceeds the benchmark period CPI–U (as defined in subparagraph (E) ) . ”
